Your browser doesn't support javascript.
loading
Tailoring neoadjuvant treatment of HR-positive/HER2-negative breast cancers: Which role for gene expression assays?
Garufi, Giovanna; Carbognin, Luisa; Arcanà, Concetta; Parola, Sara; Ventriglia, Anna; Doronzo, Antonio; Garutti, Mattia; Orlandi, Armando; Palazzo, Antonella; Fabi, Alessandra; Bria, Emilio; Tortora, Giampaolo; Arpino, Grazia; Giuliano, Mario; Del Mastro, Lucia; De Laurentiis, Michelino; Puglisi, Fabio.
Afiliación
  • Garufi G; Università Cattolica Del Sacro Cuore, Roma, Italy. Electronic address: giovanna.garufi@unicatt.it.
  • Carbognin L; Division of Gynecologic Oncology, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy. Electronic address: luisa.carbognin@gmail.com.
  • Arcanà C; Departmentof Medical Oncology, ASST Ovest Milanese, Legnano, Italy. Electronic address: concetta.arcana@asst.ovestmi.it.
  • Parola S; Department of Medicine and Surgery, Azienda Ospedaliera Federico II, Naples, Italy. Electronic address: saraparola3@gmail.com.
  • Ventriglia A; Division of Medical Oncology, Department of Precision Medicine, University of Campania Luigi Vanvitelli, Naples, Italy. Electronic address: anna.ventriglia@gmail.com.
  • Doronzo A; Medical Oncology Unit, Policlinico Riuniti, Foggia, Italy. Electronic address: a.doronzo@hotmail.it.
  • Garutti M; CRO aviano, National Cancer Institute, IRCCS, Aviano, Italy. Electronic address: mattia.garutti@cro.it.
  • Orlandi A; Department of Medical Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy. Electronic address: armando.orlandi@policlinicogemelli.it.
  • Palazzo A; Department of Medical Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy. Electronic address: antonella.palazzo@policlinicogemelli.it.
  • Fabi A; Unit of Precision Medicine in Senology, Scientific Directorate, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Roma, Italy. Electronic address: alessandra.fabi@policlinicogemelli.it.
  • Bria E; Università Cattolica Del Sacro Cuore, Roma, Italy; Department of Medical Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy. Electronic address: emilio.bria@unicatt.it.
  • Tortora G; Università Cattolica Del Sacro Cuore, Roma, Italy; Department of Medical Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy. Electronic address: giampaolo.tortora@policlinicogemelli.it.
  • Arpino G; Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy. Electronic address: graziaarp@hotmail.com.
  • Giuliano M; Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy. Electronic address: m.giuliano@unina.it.
  • Del Mastro L; Department of Medical Oncology, Breast Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy; Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genoa, Genoa, Italy. Electronic address: lucia.delmastro@unige.it.
  • De Laurentiis M; Department of Breast and Thoracic Oncology, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy. Electronic address: m.delaurentiis@istitutotumori.na.it.
  • Puglisi F; Department of Medical Oncology, Unit of Medical Oncology and Cancer Prevention, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy; Department of Medicine (DAME), University of Udine, Udine, Italy. Electronic address: fabio.puglisi@uniud.it.
Cancer Treat Rev ; 110: 102454, 2022 Nov.
Article en En | MEDLINE | ID: mdl-35987149

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Terapia Neoadyuvante Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Treat Rev Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Terapia Neoadyuvante Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Treat Rev Año: 2022 Tipo del documento: Article